دورية أكاديمية
Ticagrelor versus prasugrel in acute coronary syndrome: sex-specific analysis from the RENAMI Registry
| العنوان: | Ticagrelor versus prasugrel in acute coronary syndrome: sex-specific analysis from the RENAMI Registry |
|---|---|
| المؤلفون: | Al Raisi, Sara, Protty, Majd, Raposeiras-Roubín, Sergio, D'Ascenzo, Fabrizio, Abu-Assi, Emad, Ariza-Solé, Albert, Manzano-Fernández, Sergio, Templin, Christian, Velicki, Lazar, Xanthopoulou, Ioanna, Cerrato, Enrico, Quadri, Giorgio, Rognoni, Andrea, Boccuzzi, Giacomo, Montabone, Andrea, Taha, Salma, Durante, Alessandro, Gili, Sebastiano, Magnani, Giulia, Autelli, Michele, Grosso, Alberto, Flores-Blanco, Pedro, Varbella, Ferdinando, Cespón-Fernández, María, Gallo, Diego, Morbiducci, Umberto, Domínguez-Rodríguez, Alberto, Cequier, Ángel, Gaita, Fiorenzo, Alexopoulos, Dimitrios, Valgimigli, Marco, Íñiguez-Romo, Andrés, Kinnaird, Tim |
| المساهمون: | Al Raisi, Sara, Protty, Majd, Raposeiras-Roubín, Sergio, D'Ascenzo, Fabrizio, Abu-Assi, Emad, Ariza-Solé, Albert, Manzano-Fernández, Sergio, Templin, Christian, Velicki, Lazar, Xanthopoulou, Ioanna, Cerrato, Enrico, Quadri, Giorgio, Rognoni, Andrea, Boccuzzi, Giacomo, Montabone, Andrea, Taha, Salma, Durante, Alessandro, Gili, Sebastiano, Magnani, Giulia, Autelli, Michele, Grosso, Alberto, Flores-Blanco, Pedro, Varbella, Ferdinando, Cespón-Fernández, María, Gallo, Diego, Morbiducci, Umberto, Domínguez-Rodríguez, Alberto, Cequier, Ángel, Gaita, Fiorenzo, Alexopoulos, Dimitrio, Valgimigli, Marco, Íñiguez-Romo, André, Kinnaird, Tim |
| بيانات النشر: | EDIZIONI MINERVA MEDICA |
| سنة النشر: | 2021 |
| المجموعة: | PORTO@iris (Publications Open Repository TOrino - Politecnico di Torino) |
| مصطلحات موضوعية: | Acute coronary syndrome, Dual anti-platelet therapy, Ticagrelor, Prasugrel |
| الوصف: | BACKGROUND: The use of potent P2Y12 inhibitors (ticagrelor & prasugrel) in acute coronary syndrome (ACS) patients undergoing percutaneous coronary interventions (PCI) is a class I recommendation. We performed a sex-specific analysis comparing the difference in efficacy and safety outcomes between ticagrelor and prasugrel in a real-world ACS population.METHODS: Data from the multicenter REgistry of New Antiplatelets in patients with Myocardial Infarction (RENAMI) for 4424 ACS patients who underwent PCI and were treated with ticagrelor or prasugrel between 2012 to 2016 were analyzed. Mean follow-up was 17 +/- 9 months.RESULTS: After propensity score matching, there was no significant difference in the occurrence of primary endpoint of net adverse cardiac events between ticagrelor and prasugrel in men (HR: 0.94; 95% CI: 0.69-1.29; P=0.71), or women (HR: 1.17; 95% CI: 0.63-2.20; P=0.62; P interaction [sex] = 0.40). Similarly, no differences were found in the occurrence of any of the secondary endpoints (MACE, all cause death, re-infarction, stent thrombosis, BARC major bleeding and BARC any bleeding) between the two P2Y12 groups between men and women.CONCLUSIONS: In this real-world ACS population, no relative difference in efficacy or safety outcomes were found between ticagrelor and prasugrel between sexes. |
| نوع الوثيقة: | article in journal/newspaper |
| وصف الملف: | ELETTRONICO |
| اللغة: | English |
| العلاقة: | info:eu-repo/semantics/altIdentifier/wos/WOS:000698614400006; volume:69; issue:4; firstpage:408; lastpage:416; numberofpages:9; journal:MINERVA CARDIOLOGY AND ANGIOLOGY; https://hdl.handle.net/11583/2978598Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85117425791; https://doi.org/10.23736/S2724-5683.21.05591-5Test |
| DOI: | 10.23736/S2724-5683.21.05591-5 |
| الإتاحة: | https://doi.org/10.23736/S2724-5683.21.05591-5Test https://hdl.handle.net/11583/2978598Test |
| حقوق: | info:eu-repo/semantics/openAccess |
| رقم الانضمام: | edsbas.A2F9DFE9 |
| قاعدة البيانات: | BASE |
| DOI: | 10.23736/S2724-5683.21.05591-5 |
|---|